心血管カテーテル市場：カテーテル別、使用性別、エンドユーザー別-2025～2030年の世界予測

心血管カテーテル市場は、2023年に127億9,000万米ドルと評価され、2024年には137億1,000万米ドルに達すると予測され、CAGR 7.41％で成長し、2030年には211億米ドルに達すると予測されています。

心血管カテーテル市場は、主に心臓に関連する疾患の診断と治療における用途によって定義され、その範囲は広いです。これらのカテーテルは、血管造影、血管形成、電気生理学、カテーテルアブレーションなどの処置に不可欠です。心血管カテーテルの必要性は、人口の高齢化、ライフスタイルの変化、高血圧や糖尿病などの危険因子の増加により、世界的に心血管疾患の有病率が上昇していることに起因しています。最終用途の範囲は主に病院、外来手術センター、心臓専門医療センターであり、これらのセンターではルーチンと複雑な心臓血管処置の両方にこれらの機器を利用しています。市場成長は、技術の進歩、医療費の増加、心血管医療インフラを支援する政府の好意的な取り組みに大きく影響されます。最新の潜在的なビジネス機会としては、診断能力と患者モニタリングを強化するセンサー内蔵のスマートカテーテルの開発が挙げられます。企業への提言としては、低侵襲カテーテルを開発するための研究技術革新への投資や、医療インフラが成長しつつある新興国市場の開拓などが挙げられます。しかし、厳しい規制要件、先進的カテーテル技術に伴う高コスト、手技合併症の可能性などの課題もあります。さらに、競合情勢から市場抑制要因が生じる可能性もあり、大手企業が大きな市場シェアを占めているため、新規参入企業にとっては参入障壁となっています。これらを克服するために、企業は製品提供と市場浸透を強化するための共同研究や提携に注力することが考えられます。技術革新のセグメントには、カテーテル用の生体適合性材料、患者の安全性の向上、感染リスクの低減などがあります。さらに、カテーテルのナビゲーションと留置にAIと機械学習を組み込むことで、手技の精度を大幅に向上させることができます。同市場は、継続的な技術進化と患者中心の医療へのシフトを特徴とするダイナミックな市場であり、継続的な研究と適応が事業の持続的成長に不可欠となっています。

市場力学：急速に進化する心血管カテーテル市場の主要市場洞察を公開

心血管カテーテル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管疾患有病率の上昇
  • イメージング技術の急速な進歩
  • 心血管疾患管理に対する政府の取り組み
• 市場抑制要因
  • 心臓カテーテル検査に伴う合併症や問題点
• 市場機会
  • 先進的な心臓カテーテルの採用
  • 冠動脈インターベンション治療に対する有望な償還施策
• 市場課題
  • 製品承認のための厳しい規制基準

ポーターのファイブフォース：心血管カテーテル市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心血管カテーテル市場における外部からの影響の把握

外部マクロ環境要因は、心血管カテーテル市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：心血管カテーテル市場における競合情勢の把握

心血管カテーテル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：心血管カテーテル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心血管カテーテル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：心血管カテーテル市場における成功への道筋を描く

心血管カテーテル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患の罹患率が上昇
    • 画像技術の急速な進歩
    • 心血管疾患管理に関する政府の取り組み
  • 抑制要因
    • 心臓カテーテル法に伴う合併症と問題点
  • 機会
    • 先進心臓カテーテルの採用
    • 冠動脈介入手術に対する有望な償還施策
  • 課題
    • 製品承認に関する厳格な規制基準
• 市場セグメンテーション分析
  • カテーテル：世界的に増加している冠動脈疾患の発生率に対応するため、経皮経管冠動脈形成術用バルーンカテーテル（PTCA）の利用を拡大
  • エンドユーザー：世界中の病院施設のアップグレードと拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 心血管カテーテル市場：カテーテル別

• イントロダクション
• 電気生理学カテーテル
• ガイド延長カテーテル
• 血管内超音波カテーテル
• 経皮経管血管形成術バルーンカテーテル
• 経皮経管冠動脈形成術バルーンカテーテル

第7章 心血管カテーテル市場：使用性別

• イントロダクション
• 使い捨て
• 再利用可能

第8章 心血管カテーテル市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• クリニック
• 病院

第9章 南北アメリカの心血管カテーテル市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の心血管カテーテル市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心血管カテーテル市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Cook Medical、Bentleyと提携し米国でBeBackクロッシングカテーテルを販売
  • BiotronikによるMicro Rxマイクロカテーテルの採用、経皮的冠動脈インターベンションにおけるガイドワイヤのサポートが強化
  • 強化型衝撃波C2+カテーテルの採用、心血管治療の改善が期待
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AngioDynamics Inc.
• Asahi Intecc Co., Ltd.
• B. Braun SE
• Becton, Dickinson and Company
• Boston Scientific Corp.
• Cardinal Health
• Coloplast Corp.
• Cook Group Incorporated
• Cordis Corporation
• Edwards Lifesciences
• Getinge AB
• Infraredx by Nipro Corp.
• Integer Holdings Corp.
• Johnson & Johnson Services, Inc.
• McKesson Medical-Surgical Inc.
• Medtronic PLC
• Merit Medical Systems
• Microport Scientific Corp.
• Penumbra, Inc.
• Smith+Nephew PLC
• Stryker Corporation
• Teleflex Inc.
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. CARDIOVASCULAR CATHETERS MARKET RESEARCH PROCESS
• FIGURE 2. CARDIOVASCULAR CATHETERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CARDIOVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CARDIOVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIOVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIOVASCULAR CATHETERS MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY ELECTROPHYSIOLOGY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY GUIDE EXTENSION CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY INTRAVASCULAR ULTRASOUND CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOONS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY BALLOONS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CARDIOVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 32. CANADA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 48. CHINA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 49. CHINA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 51. INDIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 52. INDIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 103. ITALY CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 104. ITALY CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 115. POLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 116. POLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 118. QATAR CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 119. QATAR CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM CARDIOVASCULAR CATHETERS MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM CARDIOVASCULAR CATHETERS MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM CARDIOVASCULAR CATHETERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. CARDIOVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. CARDIOVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiovascular Catheters Market was valued at USD 12.79 billion in 2023, expected to reach USD 13.71 billion in 2024, and is projected to grow at a CAGR of 7.41%, to USD 21.10 billion by 2030.

The cardiovascular catheters market encompasses a broad scope, defined primarily by its applications in diagnosing and treating heart-related conditions. These catheters are essential in procedures such as angiography, angioplasty, electrophysiology, and catheter ablation. The necessity of cardiovascular catheters stems from the rising prevalence of cardiovascular diseases globally, driven by aging populations, lifestyle changes, and increasing risk factors such as hypertension and diabetes. End-use scope primarily covers hospitals, ambulatory surgical centers, and specialized cardiac care centers, which utilize these devices for both routine and complex cardiovascular procedures. Market growth is significantly influenced by technological advancements, increasing healthcare expenditure, and favorable government initiatives supporting cardiovascular health infrastructures. The latest potential opportunities include the development of smart catheters with integrated sensors, which offer enhanced diagnostic capabilities and patient monitoring. Recommendations for businesses include investing in research and innovation to develop minimally invasive catheters and exploring emerging markets with a growing healthcare infrastructure. However, the market also faces challenges, such as stringent regulatory requirements, high costs associated with advanced catheter technologies, and the potential for procedural complications. Additionally, market limitations may arise from the competitive landscape, with major players holding significant market shares, creating entry barriers for new entrants. To overcome these, businesses could focus on collaborations and partnerships to enhance product offerings and market penetration. Areas of innovation include biocompatible materials for catheters, enhancing patient safety and reducing infection risks. Furthermore, integrating AI and machine learning in catheter navigation and placement can significantly improve procedural accuracy. The market is dynamic, characterized by continuous technological evolution and a shift towards patient-centered care, making ongoing research and adaptation crucial for sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Catheters Market

The Cardiovascular Catheters Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiovascular disease across the globe
  • Surging advancements in the imaging technologies
  • Government initiatives for the cardiovascular diseases management
• Market Restraints
  • Associated complications and issues with cardiac catheterization
• Market Opportunities
  • Introduction of advanced cardiac catheters
  • Promising reimbursement policies for coronary intervention procedures
• Market Challenges
  • Stringent regulatory norms for the product approvals

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Catheters Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Catheters Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Catheters Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Catheters Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Catheters Market

A detailed market share analysis in the Cardiovascular Catheters Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Catheters Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Catheters Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Catheters Market

A strategic analysis of the Cardiovascular Catheters Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics Inc., Asahi Intecc Co., Ltd., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corp., Cardinal Health, Coloplast Corp., Cook Group Incorporated, Cordis Corporation, Edwards Lifesciences, Getinge AB, Infraredx by Nipro Corp., Integer Holdings Corp., Johnson & Johnson Services, Inc., McKesson Medical-Surgical Inc., Medtronic PLC, Merit Medical Systems, Microport Scientific Corp., Penumbra, Inc., Smith+Nephew PLC, Stryker Corporation, Teleflex Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Catheters Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Catheters, market is studied across Electrophysiology Catheters, Guide Extension Catheter, Intravascular Ultrasound Catheters, Percutaneous Transluminal Angioplasty Balloons Catheters, and Percutaneous Transluminal Coronary Angioplasty Balloons Catheters.
• Based on Usability, market is studied across Disposable and Reusable.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular disease across the globe
    • 5.1.1.2. Surging advancements in the imaging technologies
    • 5.1.1.3. Government initiatives for the cardiovascular diseases management
  • 5.1.2. Restraints
    • 5.1.2.1. Associated complications and issues with cardiac catheterization
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of advanced cardiac catheters
    • 5.1.3.2. Promising reimbursement policies for coronary intervention procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory norms for the product approvals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Catheters: Expanding utilization of percutaneous transluminal coronary angioplasty balloon catheters (PTCA) to cater to the growing global incidence of coronary artery diseases
  • 5.2.2. End-User: Upgradation and expansion of hospital facilities across the world
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiovascular Catheters Market, by Catheters

• 6.1. Introduction
• 6.2. Electrophysiology Catheters
• 6.3. Guide Extension Catheter
• 6.4. Intravascular Ultrasound Catheters
• 6.5. Percutaneous Transluminal Angioplasty Balloons Catheters
• 6.6. Percutaneous Transluminal Coronary Angioplasty Balloons Catheters

7. Cardiovascular Catheters Market, by Usability

• 7.1. Introduction
• 7.2. Disposable
• 7.3. Reusable

8. Cardiovascular Catheters Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Clinics
• 8.4. Hospitals

9. Americas Cardiovascular Catheters Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiovascular Catheters Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Catheters Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Cook Medical Partners with Bentley to Distribute BeBack Crossing Catheter in the USA
  • 12.3.2. Introduction of the Micro Rx Microcatheter by Biotronik, Enhancing Guidewire Support in Percutaneous Coronary Interventions
  • 12.3.3. Introduction of Enhanced Shockwave C2+ Catheter Promises Improved Cardiovascular Treatment
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AngioDynamics Inc.
• 3. Asahi Intecc Co., Ltd.
• 4. B. Braun SE
• 5. Becton, Dickinson and Company
• 6. Boston Scientific Corp.
• 7. Cardinal Health
• 8. Coloplast Corp.
• 9. Cook Group Incorporated
• 10. Cordis Corporation
• 11. Edwards Lifesciences
• 12. Getinge AB
• 13. Infraredx by Nipro Corp.
• 14. Integer Holdings Corp.
• 15. Johnson & Johnson Services, Inc.
• 16. McKesson Medical-Surgical Inc.
• 17. Medtronic PLC
• 18. Merit Medical Systems
• 19. Microport Scientific Corp.
• 20. Penumbra, Inc.
• 21. Smith+Nephew PLC
• 22. Stryker Corporation
• 23. Teleflex Inc.
• 24. Terumo Corporation